Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotype
Authors:
- Karl GrobschmidtKGKarl Grobschmidt
- Branko PikulaBPBranko Pikula
- Klaus LechnerKLKlaus Lechner
- Peter ValentPeter Valent
- 1 February 1999
- journal article
- Published by Elsevier in Human Pathology
- Vol. 30 (2) , 188-194
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- What Have Mast Cells To Do with Edema Formation, the Consecutive Repair and Fibrinolysis?International Archives of Allergy and Immunology, 1997
- Molecular and Functional Characterization of the Urokinase Receptor on Human Mast CellsJournal of Biological Chemistry, 1997
- Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhageAtherosclerosis, 1996
- Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytesImmunology, 1996
- The urokinase receptor is required for human monocyte chemotaxis in vitro.Journal of Clinical Investigation, 1994
- Biological Effects of Disruption of the Tissue‐Type Plasminogen Activator, Urokinase‐Type Plasminogen Activator, and Plasminogen Activator Inhibitor‐1 Genes in MiceaAnnals of the New York Academy of Sciences, 1994
- Localization of plasminogen activator inhibitor‐1 production in inflamed appendix by in situ mRNA hybridizationThe Journal of Pathology, 1993
- The status of PAI-1 as a risk factor for arterial and thrombotic disease: A reviewAtherosclerosis, 1992
- Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitorCell, 1982
- Peri‐arterial mast cells in coronary atheroma and thrombosisThe Journal of Pathology and Bacteriology, 1958